Cecile Fournier-Blanc

Caen, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

Digital image analysis improves diagnostic accuracy of HER2-low and HER2-ultralow breast cancer: a step towards personalised medicine.

Digital image analysis improves diagnostic accuracy of HER2-low and HER2-ultralow breast cancer: a step towards personalised medicine.

Journal: Virchows Archiv : an international journal of pathology

Published: August 31, 2025

Homologous recombination deficiency (HRD) tests for ovarian cancer: a multicenter French phase II study (HERO).

Homologous recombination deficiency (HRD) tests for ovarian cancer: a multicenter French phase II study (HERO).

Journal: BMC cancer

Published: May 22, 2025

Long-term patient-derived ovarian cancer organoids closely recapitulate tumor of origin and clinical response.

Long-term patient-derived ovarian cancer organoids closely recapitulate tumor of origin and clinical response.

Journal: Journal of experimental & clinical cancer research : CR

Published: April 01, 2025

The PENDOR study: establishment of a panel of patient-derived tumor organoids from endometrial cancer to assess efficacy of PARP inhibitors.

The PENDOR study: establishment of a panel of patient-derived tumor organoids from endometrial cancer to assess efficacy of PARP inhibitors.

Journal: BMC cancer

Published: December 20, 2024

Automated Scoring to Assess RAD51-Mediated Homologous Recombination in Ovarian Patient-Derived Tumor Organoids.

Automated Scoring to Assess RAD51-Mediated Homologous Recombination in Ovarian Patient-Derived Tumor Organoids.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: July 23, 2024

The OVAREX study: Establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkers.

The OVAREX study: Establishment of ex vivo ovarian cancer models to validate innovative therapies and to identify predictive biomarkers.

Journal: BMC cancer

Published: April 24, 2024

Potential of PSMA for breast cancer in nuclear medicine: digital quantitative immunohistochemical analysis and implications for a theranostic approach.

Potential of PSMA for breast cancer in nuclear medicine: digital quantitative immunohistochemical analysis and implications for a theranostic approach.

Journal: BMC cancer

Published: March 04, 2024

Ascites microenvironment conditions the peritoneal pre-metastatic niche to promote the implantation of ovarian tumor spheroids: Involvement of fibrinogen/fibrin and αV and α5β1 integrins.

Ascites microenvironment conditions the peritoneal pre-metastatic niche to promote the implantation of ovarian tumor spheroids: Involvement of fibrinogen/fibrin and αV and α5β1 integrins.

Journal: Experimental cell research

Published: February 15, 2024

The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer.

The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer.

Journal: BMC cancer

Published: July 17, 2023

Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma.

Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: March 03, 2023

HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer.

HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer.

Journal: BMC cancer

Published: July 08, 2022

Impact of automated methods for quantitative evaluation of immunostaining: Towards digital pathology.

Impact of automated methods for quantitative evaluation of immunostaining: Towards digital pathology.

Journal: Frontiers in oncology

Published: April 28, 2022

Showing 1-12 of 37

Last Updated: 09/26/2026